Lingyan Ping
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 43
- Genetics 10
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- Jun Zhu (43 shared papers)Yuqin Song (41 shared papers)Yan Xie (35 shared papers)Weiping Liu (35 shared papers)Zhitao Ying (32 shared papers)Wen Ling Zheng (28 shared papers)Meifeng Tu (27 shared papers)Xiaopei Wang (27 shared papers)
- Journals
- Cancer Cell International (5 papers)Journal of Hematology & Oncology (3 papers)BMC Cancer (3 papers)Oncotarget (3 papers)Alzheimer s & Dementia (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Lingyan Ping
68 papers receiving 1.7k citations
Lingyan Ping's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 728
- Pathology and Forensic Medicine 398
- Immunology 350
- Genetics 171
- Neurology 123
Countries citing papers authored by Lingyan Ping
This map shows the geographic impact of Lingyan Ping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Ping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Ping more than expected).
Fields of papers citing papers by Lingyan Ping
This network shows the impact of papers produced by Lingyan Ping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Ping. The network helps show where Lingyan Ping may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Ping, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A safe and potent anti-CD19 CAR T cell therapy Hit paper breakdown → | 2019 | 373 |
| 2 | Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid Hit paper breakdown → | 2022 | 224 |
| 3 | 2019 | 132 | |
| 4 | 2017 | 82 | |
| 5 | 2013 | 65 | |
| 6 | 2015 | 61 | |
| 7 | 2020 | 55 | |
| 8 | 2022 | 42 | |
| 9 | 2016 | 41 | |
| 10 | 2022 | 33 | |
| 11 | 2019 | 30 | |
| 12 | 2019 | 29 | |
| 13 | 2021 | 26 | |
| 14 | 2017 | 26 | |
| 15 | 2022 | 26 | |
| 16 | 2024 | 25 | |
| 17 | 2023 | 21 | |
| 18 | 2014 | 21 | |
| 19 | 2024 | 21 | |
| 20 | 2021 | 21 |
About Lingyan Ping
Lingyan Ping is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Hematology, having authored 72 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (9 papers), CAR-T cell therapy research (7 papers), Viral-associated cancers and disorders (7 papers), Integrated Circuits and Semiconductor Failure Analysis (5 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Advancements in Semiconductor Devices and Circuit Design (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (728 citations), Pathology and Forensic Medicine (398 citations), Immunology (350 citations), Genetics (171 citations) and Neurology (123 citations). Lingyan Ping has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jun Zhu, Yuqin Song, Yan Xie, Weiping Liu, Zhitao Ying, Wen Ling Zheng, Meifeng Tu, Xiaopei Wang, Ningjing Lin and Lijuan Deng. Their work appears in journals such as Cancer Cell International, Journal of Hematology & Oncology, BMC Cancer, Oncotarget and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.